loadpatents
Patent applications and USPTO patent grants for Glasebrook; Andrew Lawrence.The latest application filed is for "anti-tnf-anti-il-17 bispecific antibodies".
Patent | Date |
---|---|
Anti-TNF-anti-IL-17 bispecific antibodies Grant 9,416,182 - Allan , et al. August 16, 2 | 2016-08-16 |
Anti-tnf-anti-il-17 Bispecific Antibodies App 20140255406 - Allan; Barrett ;   et al. | 2014-09-11 |
Methods of using a human il-17 related polypeptide to treat disease App 20060083713 - Glasebrook; Andrew Lawrence ;   et al. | 2006-04-20 |
Method for treating diabetes and obesity App 20040259780 - Glasebrook, Andrew Lawrence ;   et al. | 2004-12-23 |
Therapeutic applications of mFLINT polypeptides App 20040167074 - Bumol, Thomas Frank ;   et al. | 2004-08-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.